14-day Premium Trial Subscription Try For FreeGet Free

Volatile ride for Tempest Therapeutics Inc. stock price on Thursday moving between $3.57 and $6.45

StockInvest.us, 1 month ago

Tempest Therapeutics Inc.

The Tempest Therapeutics Inc. stock price fell by -44.34% on the last day (Thursday, 12th Oct 2023) from $7.15 to $3.98. During the last trading day the stock fluctuated 80.67% from a day low at $3.57 to a day high of $6.45. The price has fallen in 7 of the last 10 days but is still up by 1088.06% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -111 million shares and in total, 46 million shares were bought and sold for approximately $184.53 million.

On May 13, 2022, it was reported that Piper Sandler gave TPST a "Overweight" grade with a "hold" action.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Tempest Therapeutics Inc. stock with a 90% probability to be traded between $0.234 and $7.20 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Tempest Therapeutics Inc.

The Tempest Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.77 and $0.729. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, October 11, 2023, and so far it has fallen -44.34%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $2.88 between high and low, or 80.67%. For the last week, the stock has had daily average volatility of 93.92%.

Tempest Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Check full Tempest Therapeutics Inc. forecast and analysis here.